Categories
MSU Bioethics on Facebook
Tweets
- Comments are open on our latest #BioethicsInTheNews blog post on "Human Microchip Implantation: A Bridge Too Far?"… twitter.com/i/web/status/1… 14 hours ago
- Who “owns” the healthcare data about you? Learn more from Dr. Adam M. Alessio at our next Bioethics Public Seminar… twitter.com/i/web/status/1… 15 hours ago
- RT @hastingscenter: We need to join together in common purpose or our democracy will fail. Our NEW report, "Democracy in Crisis: Civic Lear… 1 day ago
- Announcing our latest #BioethicsInTheNews commentary from Dr. Sabrina Ford: "Human Microchip Implantation: A Bridge… twitter.com/i/web/status/1… 1 day ago
- RT @michiganstateu: Take time to take care of yourself. @HealthySpartans is here to help. caps.msu.edu https://t.co/DWO0Msx5Aq 2 days ago
Top Posts & Pages
Archives
Meta
Tag Archives: Christopher Contag
What level of risk will be tolerated for interventions that are developed for treating “pre-diseased” patients?
Crossing the Biology to Pathobiology Threshold: Distinguishing Precision Health from Precision Medicine Event Flyer Diseases have long been defined by their symptoms, and therefore patients have typically been treated when they are symptomatic. However, through advances in “omics,” wearable sensors, … Continue reading
Posted in Bioethics Events, Brownbag & Webinar Series, Outreach, Public Seminar Series
Tagged biomedicine, Christopher Contag, disease, event announcement, lecture, precision health, precision medicine, webinar
Comments Off on What level of risk will be tolerated for interventions that are developed for treating “pre-diseased” patients?
